|
NSMCE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.23099999999699E-05 |
| Normal-vs-Stage3 |
2.24919999999296E-05 |
| Normal-vs-Stage4 |
1.905540E-02 |
| Stage1-vs-Stage2 |
3.262000E-02 |
| Stage1-vs-Stage3 |
4.562200E-02 |
| Stage1-vs-Stage4 |
2.687200E-01 |
| Stage2-vs-Stage3 |
9.679600E-01 |
| Stage2-vs-Stage4 |
8.777400E-01 |
| Stage3-vs-Stage4 |
8.648400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
8.01949999962304E-07 |
| Normal-vs-Asian |
9.239800E-01 |
| Caucasian-vs-AfricanAmerican |
1.866570E-01 |
| Caucasian-vs-Asian |
8.801500E-03 |
| AfricanAmerican-vs-Asian |
1.090170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.71030000162276E-08 |
| Male-vs-Female |
3.301200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.51530000000755E-06 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.8359999621207E-09 |
| Normal-vs-Extreme_Obese |
1.745910E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.020010E-01 |
| Normal_Weight-vs-Obese |
3.225400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.018000E-01 |
| Extreme_Weight-vs-Obese |
7.030800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.937220E-01 |
| Obese-vs-Extreme_Obese |
4.225200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.227790E-02 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
9.046000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.940400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.080200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.315400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.104400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.275600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.360590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
6.54389997745142E-09 |
| Normal-VS-KIRP CIMP |
8.987600E-01 |
| Normal-VS-Unclassified PRCC |
1.05880000322855E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.584070E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.595900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.668200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.877970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.709810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.986100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67759994784689E-09 |
| Normal-vs-N1 |
7.438100E-04 |
| Normal-vs-N2 |
2.573800E-01 |
| N0-vs-N1 |
1.115240E-01 |
| N0-vs-N2 |
6.438400E-01 |
| N1-vs-N2 |
7.744200E-01 |
|
|
